Treatment of hypertriglyceridemia with tibric acid and clofibrate. Cross-over studies, effects on lipoproteins and absence of post-drug rebound.
D000924:Anticholesteremic Agents; D002784:Cholesterol / Q000097:blood; D002994:Clofibrate / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008074:Lipoproteins / Q000037:antagonists & inhibitors / Q000097:blood; D008297:Male; D008875:Middle Aged; D010880:Piperidines / Q000627:therapeutic use*; D010919:Placebos; D012107:Research Design; D014280:Triglycerides / Q000037:antagonists & inhibitors / Q000097:blood*
D000924:Anticholesteremic Agents; D000960:Hypolipidemic Agents; D008074:Lipoproteins; D010880:Piperidines; D010919:Placebos; D014280:Triglycerides; D002784:Cholesterol; D002994:Clofibrate